Trials / Conditions / Stage II Non-Small Cell Lung Cancer AJCC v7
Stage II Non-Small Cell Lung Cancer AJCC v7
6 registered clinical trials studyying Stage II Non-Small Cell Lung Cancer AJCC v7.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy NCT03493789 | Emory University | Phase 1 |
| Terminated | Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell NCT03348748 | Roswell Park Cancer Institute | EARLY_Phase 1 |
| Completed | Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-II NCT02225405 | M.D. Anderson Cancer Center | Phase 1 |
| Active Not Recruiting | Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery NCT02201992 | ECOG-ACRIN Cancer Research Group | Phase 3 |
| Active Not Recruiting | Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer NCT01993810 | Radiation Therapy Oncology Group | Phase 3 |
| Active Not Recruiting | Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-I NCT01629498 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |